Market Value994,105,000
Total Holdings59
File Date2015-08-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
DRNA / Dicerna Pharmaceuticals Inc
KERX / Keryx Biopharmaceuticals, Inc.
TSRO / TESARO, Inc.
PBYI / Puma Biotechnology, Inc.
RGEN / Repligen Corporation
WGBS / WaferGen Bio-Systems, Inc.
TTOO / T2 Biosystems, Inc.
MDCO / Medicines Company
BPMC / Blueprint Medicines Corporation
CHRS / Coherus Oncology, Inc.
MACK / Merrimack Pharmaceuticals, Inc.
DYAX / Dyax Corp.
TROV / TrovaGene, Inc.
SCMP / Sucampo Pharmaceuticals, Inc.
NBIX / Neurocrine Biosciences, Inc.
/ Array BioPharma, Inc.
JUNO / Juno Therapeutics, Inc.
CASC / Cascadian Therapeutics, Inc.
OREX / Orexigen Therapeutics, Inc.
DRRX / DURECT Corporation
OCRX / Ocera Therapeutics, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
AGRX / Agile Therapeutics, Inc.
ZSPH / ZS Pharma, Inc.
AGEN / Agenus Inc.
ALKS / Alkermes plc
TENX / Tenax Therapeutics, Inc.
TXMD / TherapeuticsMD, Inc.
CDTX / Cidara Therapeutics, Inc.
TRVN / Trevena, Inc.
LUMO / Lumos Pharma, Inc.
ALPN / Alpine Immune Sciences, Inc.
TGTX / TG Therapeutics, Inc.
SIOX / Sio Gene Therapies Inc.
REGN / Regeneron Pharmaceuticals, Inc.
CLVS / Clovis Oncology Inc
AMGN / Amgen Inc.
RGLS / Regulus Therapeutics Inc.
ABIO / ARCA biopharma, Inc.
COLL / Collegium Pharmaceutical, Inc.
ARAV / Aravive, Inc.
SGMO / Sangamo Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc. Call
ABUS / Arbutus Biopharma Corporation
AKBA / Akebia Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
CELG / Celgene Corp.
MCRB / Seres Therapeutics, Inc.
BLUE / bluebird bio, Inc.
PTCT / PTC Therapeutics, Inc.
CNCE / Concert Pharmaceuticals Inc
RMTI / Rockwell Medical, Inc.
OMER / Omeros Corporation
SCYX / SCYNEXIS, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
H03579101 / Auris Medical Holding Ltd
INCY / Incyte Corporation
BBI / Brickell Biotech Inc
NVAX / Novavax, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
DVAX / Dynavax Technologies Corporation
AUPH / Aurinia Pharmaceuticals Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BIIB / Biogen Inc.
LRMR / Larimar Therapeutics, Inc.
XNCR / Xencor, Inc.
TARA / Protara Therapeutics, Inc.
ARDX / Ardelyx, Inc.
VXRT / Vaxart, Inc.